Grifols, S.A.

Symbol: GRFS

NASDAQ

6.94

USD

Market price today

  • 26.5012

    P/E Ratio

  • 0.4489

    PEG Ratio

  • 6.08B

    MRK Cap

  • 0.00%

    DIV Yield

Grifols, S.A. (GRFS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.38%

Operating Profit Margin

0.14%

Net Profit Margin

0.03%

Return on Assets

0.01%

Return on Equity

0.03%

Return on Capital Employed

0.05%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO:Mr. Jose Ignacio Abia Buenache
Full-time employees:23744
City:Barcelona
Address:Avinguda de la Generalitat, 152
IPO:2011-06-02
CIK:0001438569

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring–to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

General Outlook

When we look at how much money they make before expenses, they keep 0.381% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.135%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.025%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.008% return, is a testament to Grifols, S.A.'s adeptness in optimizing resource deployment. Grifols, S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.028%. Furthermore, the proficiency of Grifols, S.A. in capital utilization is underscored by a remarkable 0.046% return on capital employed.

Stock Prices

Grifols, S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.94, while its low point bottomed out at $6.38. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Grifols, S.A.'s stock market.

Liquidity Ratios

Analyzing GRFS liquidity ratios reveals its financial health of the firm. The current ratio of 278.63% gauges short-term asset coverage for liabilities. The quick ratio (62.90%) assesses immediate liquidity, while the cash ratio (22.87%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio278.63%
Quick Ratio62.90%
Cash Ratio22.87%

Profitability Ratios

GRFS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.81% underscores its earnings before tax deductions. The effective tax rate stands at 24.42%, revealing its tax efficiency. The net income per EBT, 52.17%, and the EBT per EBIT, 35.59%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 13.52%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.81%
Effective Tax Rate24.42%
Net Income per EBT52.17%
EBT per EBIT35.59%
EBIT per Revenue13.52%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.79, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding63
Days of Inventory Outstanding310
Operating Cycle355.23
Days of Payables Outstanding73
Cash Conversion Cycle282
Receivables Turnover8.11
Payables Turnover5.01
Inventory Turnover1.18
Fixed Asset Turnover1.57
Asset Turnover0.31

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.31, and free cash flow per share, -0.05, depict cash generation on a per-share basis. The cash per share value, 0.95, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.03, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.31
Free Cash Flow per Share-0.05
Cash per Share0.95
Operating Cash Flow Sales Ratio0.03
Free Cash Flow to Operating Cash Flow Ratio-0.18
Cash Flow Coverage Ratio0.02
Short Term Coverage Ratio0.23
Capital Expenditure Coverage Ratio0.85
Dividend Paid and Capex Coverage Ratio0.85

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 42.48%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.56, we discern the balance between debt and equity financing. The long-term debt to capitalization, 58.50%, and total debt to capitalization, 61.00%, ratios shed light on its capital structure. An interest coverage of 2.33 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio42.48%
Debt Equity Ratio1.56
Long Term Debt to Capitalization58.50%
Total Debt to Capitalization61.00%
Interest Coverage2.33
Cash Flow to Debt Ratio0.02
Company Equity Multiplier3.68

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 9.71, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.09, reflects the portion of profit attributed to each share. The book value per share, 8.58, represents the net asset value distributed per share, while the tangible book value per share, -2.43, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share9.71
Net Income Per Share0.09
Book Value Per Share8.58
Tangible Book Value Per Share-2.43
Shareholders Equity Per Share8.58
Interest Debt Per Share14.18
Capex Per Share-0.44

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 8.71%, indicates top-line expansion, while the gross profit growth, 4.09%, reveals profitability trends. EBIT growth, -8.41%, and operating income growth, -8.41%, offer insights into operational profitability progression. The net income growth, -71.52%, showcases bottom-line expansion, and the EPS growth, -71.84%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth8.71%
Gross Profit Growth4.09%
EBIT Growth-8.41%
Operating Income Growth-8.41%
Net Income Growth-71.52%
EPS Growth-71.84%
EPS Diluted Growth-71.84%
Weighted Average Shares Growth0.10%
Weighted Average Shares Diluted Growth0.10%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth2016.66%
Free Cash Flow Growth77.45%
10-Year Revenue Growth per Share141.11%
5-Year Revenue Growth per Share48.14%
3-Year Revenue Growth per Share24.44%
10-Year Operating CF Growth per Share-64.72%
5-Year Operating CF Growth per Share-71.52%
3-Year Operating CF Growth per Share-81.09%
10-Year Net Income Growth per Share-82.79%
5-Year Net Income Growth per Share-89.98%
3-Year Net Income Growth per Share-90.33%
10-Year Shareholders Equity Growth per Share178.10%
5-Year Shareholders Equity Growth per Share39.04%
3-Year Shareholders Equity Growth per Share14.99%
10-Year Dividend per Share Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth7.42%
Inventory Growth8.06%
Asset Growth-0.37%
Book Value per Share Growth-5.03%
Debt Growth3.77%
R&D Expense Growth-8.47%
SGA Expenses Growth5.36%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 16,690,034,512.419, captures the company's total value, considering both debt and equity. Income quality, 3.51, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.19, gauges operational efficiency, while the research and development to revenue, 5.01%, highlights investment in innovation. The ratio of intangibles to total assets, 44.91%, indicates the value of non-physical assets, and capex to operating cash flow, -141.84%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value16,690,034,512.419
Income Quality3.51
Sales General and Administrative to Revenue0.19
Research and Development to Revenue5.01%
Intangibles to Total Assets44.91%
Capex to Operating Cash Flow-141.84%
Capex to Revenue-4.48%
Capex to Depreciation-66.85%
Graham Number4.11
Return on Tangible Assets0.50%
Graham Net Net-15.44
Working Capital4,136,301,000
Tangible Asset Value-1,648,031,000
Net Current Asset Value-7,016,473,000
Invested Capital2
Average Receivables782,840,000
Average Payables772,516,000
Average Inventory3,330,317,000
Days Sales Outstanding45
Days Payables Outstanding70
Days of Inventory On Hand296
ROIC3.61%
ROE0.01%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.75, and the price to book ratio, 0.75, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.86, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -154.33, and price to operating cash flows, 20.99, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.75
Price to Book Ratio0.75
Price to Sales Ratio0.86
Price Cash Flow Ratio20.99
Price Earnings to Growth Ratio0.45
Enterprise Value Multiple-3.53
Price Fair Value0.75
Price to Operating Cash Flow Ratio20.99
Price to Free Cash Flows Ratio-154.33
Price to Tangible Book Ratio1.22
Enterprise Value to Sales2.53
Enterprise Value Over EBITDA14.15
EV to Operating Cash Flow80.13
Earnings Yield0.84%
Free Cash Flow Yield-1.23%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Grifols, S.A. (GRFS) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 26.501 in 2024.

What is the ticker symbol of Grifols, S.A. stock?

The ticker symbol of Grifols, S.A. stock is GRFS.

What is company IPO date?

IPO date of Grifols, S.A. is 2011-06-02.

What is company current share price?

Current share price is 6.940 USD.

What is stock market cap today?

The market cap of stock today is 6080734657.000.

What is PEG ratio in 2024?

The current 0.449 is 0.449 in 2024.

What is the number of employees in 2024?

In 2024 the company has 23744.